Personal information

Countries

United States, India

Activities

Collapse all

Works (21)

Inhibition of indoleamine dioxygenase leads to better control of tuberculosis adjunctive to chemotherapy

JCI Insight
2023-01-24 | Journal article
DOI: 10.1172/jci.insight.163101
Contributors: Bindu Singh; Chivonne Moodley; Dhiraj K. Singh; Ruby A. Escobedo; Riti Sharan; Garima Arora; Shashank R. Ganatra; Vinay Shivanna; Olga Gonzalez; Shannan Hall-Ursone et al.
Source: check_circle
Crossref

Isoniazid and rifapentine treatment effectively reduces persistent M. tuberculosis infection in macaque lungs

Journal of Clinical Investigation
2022-09-15 | Journal article
DOI: 10.1172/JCI161564
Contributors: Riti Sharan; Shashank R. Ganatra; Dhiraj K. Singh; Journey Cole; Taylor W. Foreman; Rajesh Thippeshappa; Charles A. Peloquin; Vinay Shivanna; Olga Gonzalez; Cheryl L. Day et al.
Source: check_circle
Crossref

Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates

Trends in Molecular Medicine
2022-02 | Journal article
DOI: 10.1016/j.molmed.2021.12.001
Part of ISSN: 1471-4914
Contributors: Shashank Ganatra
Source: Self-asserted source
Shashank Ganatra

Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model

Journal of Clinical Investigation
2022-02-01 | Journal article
DOI: 10.1172/JCI153090
Contributors: Riti Sharan; Shashank R. Ganatra; Allison N. Bucsan; Journey Cole; Dhiraj K. Singh; Xavier Alvarez; Maya Gough; Cynthia Alvarez; Alyssa Blakley; Justin Ferdin et al.
Source: check_circle
Crossref

Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas

mBio
2021-12-21 | Journal article
DOI: 10.1128/mbio.03189-21
Part of ISSN: 2150-7511
Contributors: Shashank Ganatra
Source: Self-asserted source
Shashank Ganatra

The voltage-gated proton channel Hv1 promotes microglia-astrocyte communication and neuropathic pain after peripheral nerve injury.

Molecular brain
2021-06-28 | Journal article
DOI: 10.1186/s13041-021-00812-8
PMID: 34183051
PMC: PMC8240390
Source: Self-asserted source
Shashank Ganatra

Visualizing the dynamics of tuberculosis pathology using molecular imaging.

The Journal of clinical investigation
2021-03-01 | Journal article
DOI: 10.1172/jci145107
PMID: 33645551
PMC: PMC7919721
Source: Self-asserted source
Shashank Ganatra

Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets.

Nature microbiology
2020-12-18 | Journal article
DOI: 10.1038/s41564-020-00841-4
PMID: 33340034
PMC: PMC7890948
Source: Self-asserted source
Shashank Ganatra

Antiretroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV coinfection model

Journal of Clinical Investigation
2020-08-24 | Journal article
DOI: 10.1172/JCI136502
Contributors: Shashank R. Ganatra; Allison N. Bucşan; Xavier Alvarez; Shyamesh Kumar; Ayan Chatterjee; Melanie Quezada; Abigail Fish; Dhiraj K. Singh; Bindu Singh; Riti Sharan et al.
Source: check_circle
Crossref

Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment

JCI Insight
2020-07-23 | Journal article
DOI: 10.1172/jci.insight.137858
Contributors: Uma Shanmugasundaram; Allison N. Bucsan; Shashank R. Ganatra; Chris Ibegbu; Melanie Quezada; Robert V. Blair; Xavier Alvarez; Vijayakumar Velu; Deepak Kaushal; Jyothi Rengarajan
Source: check_circle
Crossref

Chronic Immune Activation in TB/HIV Co-infection.

Trends in microbiology
2020-04-22 | Journal article
DOI: 10.1016/j.tim.2020.03.015
PMID: 32417227
PMC: PMC7390597
Source: Self-asserted source
Shashank Ganatra

Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis in Rabbits and Humans.

Antimicrobial agents and chemotherapy
2019-09-23 | Journal article
DOI: 10.1128/aac.00913-19
PMID: 31383662
PMC: PMC6761520
Source: Self-asserted source
Shashank Ganatra

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2019-04-03 | Journal article
DOI: 10.1016/j.ijid.2019.03.036
PMID: 30953827
Source: Self-asserted source
Shashank Ganatra

Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic.

BMC infectious diseases
2019-01-28 | Journal article
DOI: 10.1186/s12879-019-3726-8
PMID: 30691407
PMC: PMC6350313
Source: Self-asserted source
Shashank Ganatra

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery.

The Journal of infection
2018-08-07 | Journal article
DOI: 10.1016/j.jinf.2018.08.003
PMID: 30096332
Source: Self-asserted source
Shashank Ganatra

Catastrophic costs of treating drug resistant TB patients in a tertiary care hospital in India.

The Indian journal of tuberculosis
2018-04-17 | Journal article
DOI: 10.1016/j.ijtb.2018.04.011
PMID: 30797290
Source: Self-asserted source
Shashank Ganatra

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.

Emerging infectious diseases
2017-10-17 | Journal article
DOI: 10.3201/eid2310.170834
PMID: 28758888
PMC: PMC5621558
Source: Self-asserted source
Shashank Ganatra

Denying access to bedaqualine in India costs lives.

The Lancet. Infectious diseases
2017-08-01 | Journal article
DOI: 10.1016/s1473-3099(17)30400-0
PMID: 28741541
Source: Self-asserted source
Shashank Ganatra

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

The European respiratory journal
2017-05-21 | Journal article
DOI: 10.1183/13993003.00387-2017
PMID: 28529205
Source: Self-asserted source
Shashank Ganatra

Compassionate use of bedaquiline in highly drug-resistant tuberculosis patients in Mumbai, India.

The European respiratory journal
2017-03-22 | Journal article
DOI: 10.1183/13993003.01699-2016
PMID: 28331036
Source: Self-asserted source
Shashank Ganatra

Therapeutic choices in rifampicin-resistant tuberculosis.

The Lancet. Infectious diseases
2016-11-01 | Journal article
DOI: 10.1016/s1473-3099(16)30399-1
PMID: 27788974
Source: Self-asserted source
Shashank Ganatra
How many people are using ORCID?